Biolife Solutions (BLFS) Shares Outstanding (Diluted Average) (2011 - 2026)

Biolife Solutions (BLFS) has 12 years of Shares Outstanding (Diluted Average) data on file, last reported at $49.2 million in Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $49.2 million, up 1.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $49.2 million (up 1.82% YoY), and the FY2025 annual result was $48.6 million, up 5.6% from the prior year.
• Shares Outstanding (Diluted Average) climbed to $49.2 million in Q1 2026 per BLFS's latest filing, from $48.6 million in the prior quarter.
• Over five years, Shares Outstanding (Diluted Average) peaked at $49.2 million in Q1 2026 and troughed at $42.4 million in Q3 2022.
• A 5-year average of $45.4 million and a median of $45.7 million in 2024 frame the typical range for Shares Outstanding (Diluted Average).
• On a YoY basis, Shares Outstanding (Diluted Average) climbed as much as 11.87% in 2022 and fell as far as 2.13% in 2022.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $43.1 million in 2022, then advanced by 1.5% to $43.7 million in 2023, then gained by 5.37% to $46.1 million in 2024, then increased by 5.6% to $48.6 million in 2025, then rose by 1.24% to $49.2 million in 2026.
• Business Quant data shows BLFS's Shares Outstanding (Diluted Average) at $49.2 million in Q1 2026, $48.6 million in Q4 2025, and $47.6 million in Q3 2025.